Skip to main content
Market intelligence
RPRXHealthcare

Royalty Pharma plc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jun 24, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 24, 2026Marshall UristEVP, Research & InvestmentsSale9,098$55.18$502,067
Jun 23, 2026Christopher HiteEVP & Chairman, PartneringSale150,000$54.40$8,159,280
May 26, 2026Terrance P. CoyneEVP & CFOSale64,399$53.98$3,476,116